CBD: The Truth Be Told

Matt Rize

Hashmaster
Today I want to to post about CBD. First is the basics to explain what CBD is and why it is important. Then some really killer insight from Sam the Skunkman about smoking pure THC and other pure compounds. After that we look at high CBD strains in a peer reviewed article about the effectiveness of CBD from the Society of Cannabis Clinicians.

Cannabis contains over 300 compounds. At least 90 of these are phytocannabinoids which are naturally occurring compounds found within the resin glands of Cannabis. The resin glands also contain terpenes, the "essential oils" of Cannabis. Together, the phytocannabinoids and terpenes contain the many medicinal properties of Cannabis flowers and their resin. They also can get you high.

Psycho-active is a term for something that gets you high. THC is the king of psyco-active cannabinoids, and that is why THC is famous and heralded. THC is the main compound that we think of when we talk about Cannabis. But CBD, and high CBD strains are a hot topic right now, and for good reason.

The common knowledge has been that THC is responsible for the up of Cannabis sativa and CBD is responsible for the down of Cannabis indica. But it seems that high THC and high CBD may mean you get less high. And that if you desire the THC affects you should just smoke pure THC varieties with the "right" terpenes, aka right smell. It is the terpenes that work with THC to modify your high. CBD and other cannabinoids are seemingly "getting in the way" of THC and the terpenes. This may very well explain why we all smell the bag and take a deep inhale before buying, it's not just for fun. Your body is looking for the right medicine.

Here I will introduce Sam the Skunkman. If you don't know who he is... he is big time. Sam might very well be the world wide authority on cannabinoids. For the real nerds his set up is described here:

"A GC with 2 injection ports, (one column for THC and the rest of the Cannabinoids and a longer column for CBD separation) auto sampling is the way for me. Run 96 samples a night while I sleep."

Then S Skunkman goes on to say much more: "I should of said that CBD does not work by binding to the CB1 receptor. I have seen papers that refer to very very weak binding.
What CBD does do is modulate THC Binding."

"My own work shows that 100 mg pure CBD vaporized before smoking any Cannabis or THC pretty much prevents you getting any high from THC, Cannabis or hash for several hours or longer. I then tried to smoke 50% THC hash and no effect at all. While THC + CBD if consumed at the same time does not do this, you do get high like with most imported hashish, which is THC/CBD rich, but the high is quite different then a THC only hash. (I mean if the THC/CBD is smoked first thing before any other smoking.)

I have not yet tried smoking 100 mg CBD after consumption of high THC products to see what the CBD does to the THC if anything, maybe next time.

I did not like not being able to smoke and get high for 8 hours, if I wanted to. Also harder to get to sleep and real vivid dreams. Normally I don't remember my dreams if I smoke. Next morning every thing was normal.
THCV is also a THC antagonist like CBD.

-SamS"

"You mentioned Cannabinoids that get you high, like THC, CBN almost gets you high, but you can forget CBD, CBC, CBG, THCV and the rest of the propyls (3 carbon] They do not get you high, although they do have medical applications. I have tried them all as pure single Cannabinoids.

CBD, CBN, THCV are THC antagonists and they do modify THC's effects, like in the case of CBD which delays THC onset, reduces peak effects and lengthens the reduced effects time of activity.

CBD is also funny in that if you smoke 100mg of pure CBD before any Cannabis smoking, you can't get high from THC for several hours, even if you smoke the strongest hash.
While if you smoke a THC/CBD mixture first thing, you do get high, like almost all imported hash, that has considerable CBD with the THC.

But the high is different then THC only varieties. I prefer high THC only, but to each their own....

It is the terpenes with high THC that makes the subjective effects." S Skunkman

"First of all there are now over 90 identified Cannabinoids, I have tried maybe a dozen all alone and with pure THC, none get you high, except for THC and CBN if you call CBN a high. There are a few Cannabinoid modulators of THC, just a few. Most had zero effect on THC. Instead it is the Terpenoids I have found." S Skunkman

"It is the Terpenoids that with THC create all the subjective effects found in so many different varieties of Cannabis. That and CBD, CBN, THCV which are THC modulators when they are present.

Maybe we will find another terpenoid that does get you high but then why did not primitive indigenous farmers find it like they did with THC? They created pure THC varieties by eliminating anything else, all without knowing anything about THC. I suspect they would have found any other Cannabinoid that would of gotten them high, don't you?" S Skunkman
"THC selection is the hand of man, plain and simple, wild Cannabis is never high in THC, unless recently escaped from cultivation by man. Same as any other Cannabinoid that man would of selected for, if you think that Cannabis was high in THC before the hand of man you are mistaken. Without the hand of man to maintain through selection Cannabis THC Cannabinoid levels fall quickly." S Skunkman
----------------------------------------------------------------------------
Here is some great info if you want to grow some high CBD genetics from the Society of Cannabis Clinicians. Looks like I need a Trueblue/OG cut.


"Doctors to Study Effectiveness of CBD

Tod Mikuriya, MD, did not live to see it, but his dream of investigating the medical potential of compounds in the cannabis plant other than THC is now within the grasp of his successors.

The Society of Cannabis Clinicians, the group Mikuriya founded in 1999, has drafted a “Strain Evaluation Survey” to collect data from patients who medicate with cannabis in which cannabidiol (CBD) is predominant.

CBD-rich cannabis will be available at California and Colorado dispensaries by late summer —and soon thereafter, inevitably, in other states where patients can legally use cannabis as medicine.

Twelve strains rich in cannabidiol (CBD) have been identified in the year and a half since an analytic chemistry lab began testing cannabis samples provided by California dispensaries, growers, and edible makers. Buds from five of these strains have been available intermittently at Harborside Health Center in Oakland. Herbal Solutions in Long Beach also has provided CBD-rich cannabis to patients.

Eight of the CBD-rich strains are currently being grown out. The others cannot be reproduced because the growers hadn’t saved or couldn’t regain access to the genetic material that yielded their buds of interest.

More than 9,000 samples have been tested to date by the Steep Hill lab in Oakland. Other start-up labs in California, Colorado, and Montana have begun testing for the burgeoning industry. The Full Spectrum lab in Denver has tested some 4,500 strains and identified seven CBD-rich strains.

A strain that is roughly 6% CBD and 6% THC, “Cannatonic,” has been developed by Resin Seeds in Barcelona and is being grown from seed by several collectives. Its name may be misleading, since CBD supposedly cancels the sedating effects of THC.

For purposes of the data collection being planned by the Society of Cannabis Clinicians, “CBD-rich” cannabis is being defined as more than 4% cannabidiol by weight (without respect to THC content) or more than 2.5% CBD if CBD exceeds THC.

Until testing for cannabinoid content began, it was widely assumed that CBD, which is non-psychoactive, had been bred out of all the cannabis in California by generations of growers seeking maximum THC content.

Doctors in the SCC have watched with great interest in recent years as a British company, G.W. Pharmaceuticals conducted clinical trials of cannabis-plant extracts. G.W. has a license from the British government and backing from Otsuka, a Tokyo-based multinational.

G.W.’s flagship product, Sativex, is a plant extract that contains approximately equal amounts of CBD and THC. What benefits did G.W. scientists expect a CBD-rich extract to confer?

Various studies published in the medical and scientific literature suggest that CBD could be effective in easing the symptoms of rheumatoid arthritis, diabetes, nausea, and inflammatory bowel disorders, among other difficult-to-control conditions. CBD also has demonstrated neuroprotective effects, and its anti-cancer potential is being explored at several academic research centers.

An even wider market would emerge if the reduced psychoactivity of CBD-rich cannabis makes it an appealing treatment option for patients seeking anti-inflammatory, anti-pain, anti-anxiety, and/or anti-spasm effects delivered without disconcerting euphoria or lethargy.

The plant richest in CBD is a “True Blueberry/OG Kush” cross grown in the mountains south of Yreka by Wendell Lee of Full Spectrum Genetics (not to be confused with the lab in Colorado). Dried buds of TB/OGK have been sent for testing on four occasions by Harborside, the dispensary with which Lee is associated. Samples were consistently found to contain about 10% CBD (with THC levels around 6 to 7%). On the only occasion that a crop grown outdoors by Lee was tested by Steep Hill lab, it was found to contain 13.9% CBD.

Two other labs have confirmed the CBD content of Lee’s TB/OGK.

Lee is now working to “stabilize the genetics” and produce TB/OGK seeds. Several plants he provided to Project CBD (a nonprofit organized by writer/activist Martin Lee to promote research) are being grown out by experienced hands. Processed medicine and clones will be available at dispensaries in the months ahead. Details will be available on ProjectCBD.com, a website that will be launched by mid-August, according to Martin Lee (no relation to Wendell)

The California strain richest in CBD proportionally, “Women’s Collective Stinky Purple,” tested at 9.7% CBD and 1.2% THC. It was brought to Harborside by Grower #1 who also grows a strain called “Cotton Candy/Diesel” that was found to contain about 6% CBD and 6% THC. Grower #1 gets her starter plants from friends in Northeastern Mendocino County. Is there something in the genome of plants that have been swapped over the years by growers in those hills that encourages expression of CBD?

Another strain containing more than 8% CBD, grown indoors in the East Bay, was brought to Harborside in late April. “Omrita Rx3” is the name the grower has given it after learning that it was of special interest to SCC doctors.

A few weeks later a strain called “Harlequin” was found to contain about 8% CBD. And soon thereafter a pound of “Jamaican Lion” tested at 8.9% CBD. Clones of these strains are being grown out and will be available through Harborside and Project CBD in the months ahead, along with the Soma A+ that was first to be identified.

Pineapple Thai (5% CBD, 2.4% THC) is being grown out by Herbal Solutions in Long Beach."

More from this paper can be found here:

http://www.medicalmarijuana411.com/2010/11/11/doctors-to-study-effectiveness-of-cbd/

Rize out. Peace
 

moash

New Member
i see myrcene(spelling) was not mentioned....
it is supposed to help the receptor transfer more thc to the brain
high potency strains have high amounts of this...so do mangoes
eating a mango a 1/2 hr before u smoke increases the phsycoactive effect
 

Matt Rize

Hashmaster
i see myrcene(spelling) was not mentioned....
it is supposed to help the receptor transfer more thc to the brain
high potency strains have high amounts of this...so do mangoes
eating a mango a 1/2 hr before u smoke increases the phsycoactive effect
I'm addicted to organic dried mango... hmm. Isn't myrcene one of the terpenes?

"Myrcene, or β-myrcene, is an olefinic natural organic compound. It is classified as a hydrocarbon, but more precisely as a monoterpene. Terpenes are dimers of isoprene and myrcene is one of the most important. It is a component of the essential oil of the several plants including bay, ylang-ylang, wild thyme, and hops."

Hops hmm... the sole sister to Cannabis on the tree of life.
 

Total Head

Well-Known Member
that was an interesting read. i bet this information could be used to solve the age-old tolerance issue for good. or maybe it could serve to eventually kill tolerance altogether, and that would actually be bad. interesting either way.
 

moash

New Member
I'm addicted to organic dried mango... hmm. Isn't myrcene one of the terpenes?

"Myrcene, or β-myrcene, is an olefinic natural organic compound. It is classified as a hydrocarbon, but more precisely as a monoterpene. Terpenes are dimers of isoprene and myrcene is one of the most important. It is a component of the essential oil of the several plants including bay, ylang-ylang, wild thyme, and hops."

Hops hmm... the sole sister to Cannabis on the tree of life.
i guess it is
i should have known that,since in ends in -ene
rep
 

Matt Rize

Hashmaster
They tiny shiny things all over buds are really resin glands. These glands contain the special stuff. This means THC and CBD mostly, plus the smelly stuff. THC gets you high. CBD is bad if you want to get high, but good for medication. The smelly stuff actually affects the high, so smell and high are related.

If you want to grow high CBD strains, they are highlighted, highest CBD strain being trueblue/OG
 

Matt Rize

Hashmaster
Sam rejoins the conversation after some prodding and restates his view of CBD.
First of all do you mean a CBD only variety or a THC/CBD variety?
I have posted this many times, but one more time....
If you smoke a CBD only variety you do not get high. In fact if you first smoke enough pure CBD, 100 mg and it is very hard to then get high off THC for several hours or longer.
Smoke a THC/CBD variety and you do get stoned but the high is longer in onset, reduced peak experiences, and a longer but reduced high.
I do not find CBD a "more intense body stone, possibly intense "cotton mouth" and a more relaxed kind of happy pleasant, relaxing high that gives one permagrin and a lot of laughs, the kind of high you can wallow in."

I do not like CBD, it screws with THC in ways I just don't like at all. If you like the high of imported hash then maybe you would like a THC/CBD variety, as almost all imported hash has considerable CBD with the THC.
You need to understand that no one I have tested could tell if a variety had CBD in it or just had terpenoids that mimic CBD's effects. Most Cannabis in the USA has little to no CBD, yet many people believe they have smoked CBD rich varieties, that in fact contained no CBD, just because it caused couchlock and was physical.
I do not believe anyone can tell if a variety has CBD or terpenoids that mimic CBD's effects, maybe I can but I doubt it. I have varieties that everyone when they smoked them, said had to contain CBD, they were THC only.
So the real question is do you really want CBD? A few dispensaries sell confirmed tested CBD rich varieties, like Harborside in Oakland, have you obtained a CBD rich variety to try yourself? If no why not?
THC while important is flat and boring 100% pure, it is the Terpenoids + THC that create all the different subjective effects that users report.
CBD is important to people that easily get the fears from high THC varieties, and for medical users, but as almost no USA Cannabis has had CBD in it, I suspect a lot less people were describing CBD effects as they were describing varieties that have Terpenoids that have CBD like effects, like most Indicas.

100% pure CBD is an slightly off white amorphous powder that when vaporized turns to an oil. It is legal in most of Europe.
-SamS
 

Matt Rize

Hashmaster
Bastille Day Weekend Edition
July 14 / 15, 2007

Pot Shots

Who's Afraid of Cannabidiol?

By FRED GARDNER

THC -delta-9 tetrahydrocannabinol is often described inaccurately as "the active ingredient in cannabis." At least five other cannabinoids (compounds unique to the cannabis plant) have been shown to exhibit biological activity, and so have some of the spicy-smelling terpenes and other compounds found in plants other than cannabis.

CBD -Cannabidiol- is an active ingredient of cannabis that has been suppressed by growers and governments for countless generations. From Marakesh to Mendocino, plants have been bred for maximum psychoactivity, resulting in high THC and low CBD content. In the Prop 215 era, California growers hoping to develop plants with a high CBD-to-THC ratio have been stymied by lack of access to an analytical test lab. Surreptitious tests have been done on "high grade" plants whose buds turned out to be in the range of 15-20% THC and 0.1% CBD.

The U.S. Drug Enforcement Administration has placed CBD on Schedule I even though CBD has no known adverse effects and doesn't induce "euphoria." The prohibition of CBD exposes the broader marijuana prohibition as strictly a governmental control tactic having nothing to do with public health or "protecting the children." The most dire effects attributed to marijuana -tachycardia (accelerated heartbeat), panic, confusion, anxiety, even psychosis- are effects of THC that CBD actually mitigates! By banning CBD outright and denying growers the means to develop high-CBD plant strains, the government is protecting the American people from an immunomodulator with anti-inflammatory, anti-convulsant, anti-psychotic, anti-oxidant, and neuroprotective properties.

A high-CBD cannabis strain was developed in the 1980s by David Watson and Robert Clarke, American naturalists who founded a company called Hortapharm in Amsterdam to pursue their goal of developing plant strains for different purposes. (The day Watson and Clarke became expatriates is the day the U.S. lost its lead in the field of cannabis therapeutics.) In 1998 Hortapharm sold its seed stock to a British start-up, GW Pharmaceuticals, which has since developed a strain that expresses 97% of its cannabinoid content as CBD

GW plans to test its high-CBD strain as a treatment for rheumatoid arthritis, inflammatory bowel diseases, psychotic disorders, and epilepsy. It is now in Phase 2 trials to determine the dose levels to use in clinical trials involving people. GW mixes its high-CBD and high-THC strains in a 1:1 ratio to make Sativex, a plant extract formulated for spraying under the tongue that has been approved in Canada and elsewhere to treat neuropathic pain associated with multiple sclerosis. CBD evidently bolsters the pain-killing effects of THC while moderating its psychoactivity. In various studies, patients with severe pain have reported getting significantly more relief from Sativex, the mixture, than from GW's high-THC extract.


The 2007 ICRS Meeting

CBD was the subject of several talks and posters that generated buzz at this year's meeting of the International Cannabinoid Research Society, held June 26-30 at a ski resort in Saint Sauveur, Quebec. Among the promising studies: "CBD and the Neural Correlates of Anxiety," by Jose Alexandre Crippa and colleagues at King's College, London, and the Universidade de Sao Paulo. They measured blood flow in various parts of the brain as subjects viewed upsetting images and found that those who had been given an oral dose of CBD had markedly reduced responses. Iddo Magen's team at Hadassah Hebrew University in Jerusalem showed that CBD and 2-AG (one of the body's own cannabinoids) improved cognition and neurological function in mice with liver damage. Erica Carrier and co-workers at the Medical College of Wisconsin, Milwaukee, determined that CBD exerts its anti-anxiety effects by activating the adenosine receptors.

Some 350 scientists from university and drug-company laboratories attended. Merck, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, and Allergan (maker of Botox and silicone breast implants) were among the corporate participants. They are all trying to develop synthetic drugs that confer some of the health benefits of cannabis without the psychoactivity. The studies described by representatives of these companies tend not to involve their most promising drugs; or else the speakers are not wholly forthcoming about the structure of the drugs involved.

Other participants included Cayman Chemical (which supplies various companies' products to research labs), Valeant (now marketing a synthetic cannabinoid called Nabilone, developed by Eli Lilly in the 1980s), ElSohly Laboratories (Mississippi-based, the only company authorized by the DEA to grow cannabis in the U.S.), Bedrocan BV (which grows cannabis for the Dutch Ministry of Health, Welfare and Sport), Cannasat (a Canadian company with three plant-based products in their pipeline), and GW Pharmaceuticals.

Bayer Health Care, which distributes GW's Sativex in Canada, had set up a large exhibit in one of the rooms dedicated to posters. Geoffrey Guy, the head of GW, expressed embarrassment ("That's not really the sort of thing to do at a scientific conference") and pride ("I rather liked it; the materials they distributed were excellent") in a 1:1 mix.

The meeting's primary sponsor was Sanofi-Aventis, the world's third-largest drug company, which had suffered a major setback in mid-June when an FDA advisory panel voted 14-0 against recommending approval of Acomplia (also known as Rimonabant), a weight-loss drug that works by blocking the CB1 receptor. Acomplia has been approved for sale in the UK and elsewhere, and Sanofi and most securities analysts had projected it to be a blockbuster in the U.S. But the FDA advisors were troubled by the number of suicides and seizures in the clinical-trial data.

When Sanofi first announced at the 2004 ICRS meeting that Rimonabant was proving effective in large-scale trials in Europe, Jeffrey Hergenrather, MD, of Sebastopol and other California clinicians warned that reversing the effects of the body's own cannabinoid system was very likely to cause health problems. Your correspondent had published a piece quoting Hergenrather, slugged "Danger! Danger! Danger!" So it was a little awkward to encounter the charming scientists from Sanofi at this year's meeting, knowing they had just lost out on millions and might hold us partly responsible (when it fact we are under the radar and politically impotent).

Rimonabant has been used by more than 100,000 people in Europe and Sanofi contends that the safety profile may yet turn out to be satisfactory. They're also trying to figure out ways to prevent those most at risk -people with epilepsy, MS, a history of serious depression, etc. etc.- from taking Rimonabant. Unfortunately, the et ceteras are numerous. Sanofi's marketers wish they could sell Rimonabant only to diabetics for whom it would be most beneficial. They dream of applying "genomics" (analyzing every patient's genetic make-up before prescribing) but the reality is a world in which doctors can prescribe for off-label uses and everyone wants to lose 10 pounds.

The consensus among ICRS scientists is that downward modulation of the CB1 receptor is a feasible strategy for treating diabetes and metabolic syndrome, but that Rimonabant -an "inverse agonist" that doesn't simply block the receptor but achieves a reverse effect on endocannabinoid tone throughout the body- was too strong a drug. "Inverse agonists of the endocannabinoid system probably do not exist in Nature," observes Ethan Russo, MD. "Pharmaceuticals that act in such a manner may be outside physiological parameters. The normal order calls for more subtlety of function.

GW is beginning to test a plant strain high in THCV, a neutral antagonist that lightly occupies the receptor but doesn't reverse its effects on endocannabinoid tone. Guy says, "We may get tarred with the brush by those who don't understand the difference between an inverse agonist and a neutral antagonist. It's up to us to present data in due course that reflect those distinctions."

Fred Gardner edits O'Shaughnessy's, the Journal of Cannabis in Clinical

http://www.counterpunch.org/gardner07142007.html
 

RawBudzski

Well-Known Member
this is why that bud I smoked with them jamaican buddies was the trippiest shyt ever.. they must have read this. <3
 

Goldowitz

Well-Known Member
They tiny shiny things all over buds are really resin glands. These glands contain the special stuff. This means THC and CBD mostly, plus the smelly stuff. THC gets you high. CBD is bad if you want to get high, but good for medication. The smelly stuff actually affects the high, so smell and high are related.

If you want to grow high CBD strains, they are highlighted, highest CBD strain being trueblue/OG
DNA Kushberry is a cross of Blueberry and OG. The description for this strain is a lemon, zesty pheno that resembles OG. I grew this pheno and can confirm that, but I also found another pheno. It has a strong smell and taste of berries/kush. I want to have it tested some day because I suspect that it may be high in CBD.

I consider this pheno of KB to be very special, as it is the best medicine I have ever come across. It is great for pain, sleep, eating, stomach problems, stress and anxiety but it also gives a strong body high and feeling of euphoria.

It is cool to read that CBD will actually block a THC high, because I have also found the same results. If I smoke AK47 and then KB, I get a great feeling of both, but if I smoke KB first and then AK47, I don't get the good sativa high.

I have never grown a special strain that is high in CBD, so I can't say how this berry pheno compares, but I hope to change that soon. I just got 10 Cannatonic seeds and look forward to growing them out and seeing how the high is first hand.

How come a lot of people say strains like Kali Mist and C99 are good for stress and anxiety because of the high THC content while other people say THC is what causes anxiety?
 

tomato57

Well-Known Member
"How come a lot of people say strains like Kali Mist and C99 are good for stress and anxiety because of the high THC content while other people say THC is what causes anxiety?"

Could be due to other, subjective, variables rather than the pharmacology of the substances itself. Environment and setting play a big role when using psychedelics - you do get both good and bad trips on psilocybin/psilocin mushrooms regardless of the ratio and the same principle applies to THC/CBD. Anxiety is diverse and can make you feel both fatigued or stimulated; one might find the former to be alleviated by THC and the latter by CBD, but this should not be accepted as a rule as there are many variables to consider (the whole cannabinoid profile, your metabolism etc.). Nevertheless, high CBD strains should in practice, generally, decrease the incidence and severity of anxiety better than its THC counterparts because of the primary determinant, pharmacology, favoring anxiety alleviation.
 

Wolverine97

Well-Known Member
DNA Kushberry is a cross of Blueberry and OG. The description for this strain is a lemon, zesty pheno that resembles OG. I grew this pheno and can confirm that, but I also found another pheno. It has a strong smell and taste of berries/kush. I want to have it tested some day because I suspect that it may be high in CBD.

I consider this pheno of KB to be very special, as it is the best medicine I have ever come across. It is great for pain, sleep, eating, stomach problems, stress and anxiety but it also gives a strong body high and feeling of euphoria.

It is cool to read that CBD will actually block a THC high, because I have also found the same results. If I smoke AK47 and then KB, I get a great feeling of both, but if I smoke KB first and then AK47, I don't get the good sativa high.

I have never grown a special strain that is high in CBD, so I can't say how this berry pheno compares, but I hope to change that soon. I just got 10 Cannatonic seeds and look forward to growing them out and seeing how the high is first hand.

How come a lot of people say strains like Kali Mist and C99 are good for stress and anxiety because of the high THC content while other people say THC is what causes anxiety?
It's not only the cannabinoids that affect the "high", it's also the different terpenes in each different variety. It seems to me that's why most lavender strains have a more relaxing, sleepy feel to them.
 

bassman999

Well-Known Member
DNA Kushberry is a cross of Blueberry and OG. The description for this strain is a lemon, zesty pheno that resembles OG. I grew this pheno and can confirm that, but I also found another pheno. It has a strong smell and taste of berries/kush. I want to have it tested some day because I suspect that it may be high in CBD.

I consider this pheno of KB to be very special, as it is the best medicine I have ever come across. It is great for pain, sleep, eating, stomach problems, stress and anxiety but it also gives a strong body high and feeling of euphoria.

It is cool to read that CBD will actually block a THC high, because I have also found the same results. If I smoke AK47 and then KB, I get a great feeling of both, but if I smoke KB first and then AK47, I don't get the good sativa high.

I have never grown a special strain that is high in CBD, so I can't say how this berry pheno compares, but I hope to change that soon. I just got 10 Cannatonic seeds and look forward to growing them out and seeing how the high is first hand.

How come a lot of people say strains like Kali Mist and C99 are good for stress and anxiety because of the high THC content while other people say THC is what causes anxiety?
Smoking my Harlequin will stunt the thc effect of other strains smoked afterward for an hour to 2 I have noticed.
 

bassman999

Well-Known Member
It's not only the cannabinoids that affect the "high", it's also the different terpenes in each different variety. It seems to me that's why most lavender strains have a more relaxing, sleepy feel to them.
I have 2 Lavenders flowering right now...one in and one outr. I hop-e she will turn out to be something special for me as well!
 
Top